A Multicenter Phase II Clinical Trial of Neoadjuvant Trabectedin (YONDELIS®) in Patients with Localized Myxoid / Round Cell Liposarcoma

Mise à jour : Il y a 4 ans
Référence : EUCTR2007-000035-25

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

- To determine the pathological complete response (pCR) rate with trabectedin in patients with locally advanced (Stage III) myxoid / round cell liposarcoma (MRCL).


Critère d'inclusion

  • Locally advanced (Stage III) myxoid / round cell liposarcoma previously untreated with chemotherapy or radiation